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1. Introduction 
While glucocorticoids (GC) exert broad effects on metabolism, behavior and immunity, local 
production of even small amounts of GC, which may act in a paracrine or even autocrine 
manner, enable a specific site of the body to regulate their exposure to GC according to their 
specific needs. Mucosal tissues, for example, are at the borderline to the outside world, and 
are therefore in constant contact with either harmless foreign particles or potentially 
pathogenic microorganisms, which might provoke devastating inflammatory disorders due 
to chronic stimulation of the mucosal immune system. Increasing the local concentration of 
immunoregulatory GC by extra-adrenal de novo GC synthesis or local reactivation of 
inactive serum metabolites provides a protective mechanism to either restore homeostasis 
after clearance of infection or to regulate the critical balance between immunity and 
tolerance. 
2. Adrenal versus extra-adrenal GC synthesis 
Production of GC in the adrenal glands is regulated by hypothalamic-pituitary-adrenal 
(HPA) axis and follows under normal conditions the circadian rhythm. However, GC are 
also a major humoral response to various types of stress. [1]. Immunological stress by 
excessive activation of immune cells rapidly results in elevated plasma levels of tumor 
necrosis factor alpha (TNFα), interleukin (IL) -1 and IL-6, which then stimulate the HPA axis 
and lead to an increase of systemic GC [2]. These and similar signals stimulate also the local 
GC synthesis in mucosal tissues, as will be discussed later (Table 1). 
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Local GC 
synthesis 
Cellular source Special features Described functions References 
Thymus Epithelial cells 
in cortex 
Mutual 
antagonism 
Thymic selection [3-7] 
Skin 
Hair follicle 
Keratinocytes, 
melanocytes, 
fibroblasts etc. 
Autonomous 
HPA-axis 
Integrity and growth; 
response to stress 
factors 
[8-19] 
Cardiovascular 
system 
Vessel walls, 
Heart 
Together with 
mineralocorticoids
Vascular contractility 
and remodeling 
[20-29] 
Central Nervous 
system 
Neurons, glia Various 
neurosteroids 
Sensitizing GABA 
and other receptors; 
feed-back on HPA-
axis; cognitive 
functions 
[30-45] 
Intestine Crypt cells Regulation via 
LRH-1  
Immune regulation [46-53] 
Lung unknown Reactivation by 
11β-HSD 
Immune regulation [54] 
Colon carcinoma Tumor cells Regulation via 
LRH-1 
Immunosuppression [55] 
Table 1. Extra-adrenal GC sources and their functions. 
Because most data published so far on local GC synthesis has been generated in animal 
models a brief overview of steroidogenic processes in rodents compared to humans must be 
made (Figure 1). A major difference is the implication of the enzyme 17α-hydroxylase in the 
GC synthesis in humans, but not in rodents. Pregnenolone is transformed directly into 
progesterone in most rodents, and in other mammalians and humans it is first hydroxylated 
and then metabolized into 17-OH-progesterone [56]. 11β-hydroxylase (P450C11) is an 
enzyme expressed in the zonae fasciculata et reticularis and is a product of the gene 
CYP11B1. Thus, in rodents this enzyme uses 11-deoxycorticosterone as a substrate and turns 
it into corticosterone, which is the active GC in these species. In humans 11β-hydroxylase 
metabolizes mainly 11-deoxycortisol into cortisol and to a lesser degree 11-
deoxycorticosterone into corticosterone. Hence, cortisol is the major active GC in the human. 
11-Deoxyorticosterone and corticosterone are important metabolites in both species, which 
can be hydroxylised and oxidised in the zona glomerulosa of the adrenals, subsequently 
leading to the mineralcorticosteroid aldosterone [57]. 
It is well established that the adrenal glands are the major source of systemic GC. Surgical 
removal of the adrenal glands results in a rapid drop of serum GC levels, which after a 
couple of days become undetectable, illustrating that the adrenals are primarily responsible 
for the GC levels detected in the circulation [46, 58]. However, in recent years there has been 
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accumulating evidence that several other tissues are capable of producing GC and thereby 
regulate local processes in an adrenal-independent manner [7, 59]. 
 
Legend:  enzymes; □ metabolites:  metabolic pathway; - - - absent in rodents; * inhibitory effect of metyrapone. 
Figure 1. Differences in the GC synthesis pathway in rodents and humans. 
3. Extra-adrenal sources of GC synthesis 
3.1. Thymus 
The Thymus plays a central role in the development of the immune system. Thymocyte 
development and differentiation is shaped and regulated by the interaction with the thymic 
epithelial cells and the factors secreted by them [60, 61]. 
Initial characterizations of extra-adrenal GC synthesis started in the thymus. In the mid to 
late 90ties of the last century it was described that the non-immune cells in the thymic cortex 
are capable of producing various steroid metabolites. Accordingly, the expression of various 
enzymes of the corticosteroid synthesis pathway has been demonstrated in thymic epithelial 
cells [3-5]. While the function of thymic GC has been a matter of scientific debate for some 
time [62, 63], particularly the work of Ashwell and co-workers illustrated that GC 
production in the thymus has an important role in the regulation of thymocyte development 
and selection. Interestingly, while thymocytes are exquisitely sensitive to GC and rapidly 
die by apoptosis, the in situ produced corticosterone seems to oppose the signals induced by 
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the T cell receptor and thereby lower T cell receptor-induced apoptosis (negative selection). 
On the other hand T cell receptor activation also inhibits the apoptosis-inducing activity of 
GC in thymocytes [64]. Thus, the “mutual antagonism” between T cell receptor and 
glucocorticoid receptor (GR) signaling seems overall to enhance survival and thereby 
positive selection of thymocytes by increasing the threshold of T cell receptor signals 
leading to negative selection [3]. The thymus in mice produces the highest amounts of GC 
during fetal development and in the first weeks after birth. This is the time of the most 
extensive lymphocyte development and differentiation, and it occurs at a time when the 
steroidogenesis in the adrenals is not fully active. Thus, the thymus seems to depend largely 
on its own by providing the necessary GC. Whether thymic epithelial cells constitutively 
produce GC or whether this is dependent on the interaction with activated thymocytes or 
soluble factors, is presently unknown. The presence or absence of factors regulating thymic 
GC synthesis may, however, affect positive and negative selection of thymocytes, and 
thereby also affect the levels of potentially autoreactive T cells in the periphery. [6, 7]. 
3.2. Skin 
The skin is an organ with a complex structure and its purpose is to protect the inner 
organism from the environmental factors, infections, dehydration, thermal deregulations 
etc. The outer cover of the skin, the epidermis, maintains its integrity through intense self-
renewing by the proliferating keratinocytes in the basal layer and the dividing cells in the 
hair follicles. As such skin is an important component of the defense mechanisms providing 
not only a reliable mechanical barrier and producing antimicrobial enzymes and other 
substances, but also being populated with many specialized immune cells, e.g. dendritic 
cells (Langerhans cells) within the epidermis, as well as resident macrophages, dendritic 
cells and lymphocytes in the derma [65]. The skin also displays active metabolic and 
endocrine functions. Along with the synthesis of vitamin D, the skin was shown to produce 
various hormones and regulatory factors, like parathyroid-related protein, melanocyte-
stimulating hormone (MSH), β-endorphin peptides, urocortin, neurotransmitters and others 
(for review [10, 11]). With regard of this chapter’s topic of interest is the ability of the skin to 
produce all components of the HPA axis. A great contribution to the understanding of GC 
metabolism and regulation in the skin has been made by the extensive research of Slominski 
and co-workers [10]. In human keratinocytes and cells of the hair follicles expression of 
corticotropin-releasing factor (CRF) has been demonstrated at the mRNA and protein level, 
whereas in mice the local synthesis of CRF has not been proven yet. The observed local 
increased concentration of CRF in the skin could be possibly explained by its release from 
neuronal cells and its active transport into the skin along the local nerve endings [12, 15]. 
Many cell types found in the skin, e.g. keratinocytes [66], melanocytes [13], dermal 
fibroblasts [67], immune cells and endothelial cells in the derma, as well as hair follicles [16] 
and skin tissue cultures, are able to respond to CRF stimulation and to produce 
proopiomelanocortin,  which can be further processed into adrenocorticotropic hormone 
(ACTH), MSH and β -endorphin. Moreover, GC-synthesizing enzymes and active GC have 
been demonstrated in human and rodent skin.  Metabolic assays demonstrated that ex vivo 
cultured normal rat skin could transform progesterone into deoxycorticosterone and 
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corticosterone, and further to 11-dehydrocorticosterone [9]. Human skin has been 
demonstrated to respond to ACTH, to express various steroidogenic enzymes, and to be 
capable of synthesizing cortisol [8, 18]. Local steroidogenesis was demonstrated in human 
keratinocytes [19], sebaceous cells [18], fibroblasts [14], and melanocytes [13]. Hair follicles, 
also known as pilosebaceus units, appear to function as fully autonomous peripheral 
equivalents of the HPA axis. The CRF/ACTH-induced cortisol production appears to 
provide also a negative feedback on the local CRF synthesis and thereby terminate local 
steroidogenesis [15]. It has been suggested that this local HPA axis is implemented in the 
regulation of hair growth, pigmentation and modulation of local immune response [17]. 
Components of the HPA axis, mainly CRF, are proposed to affect the epithelial cell 
proliferation, apoptosis and differentiation [15]. Recent findings describe the role of local 
cortisol synthesis in a model of tissue injury. Up-regulation of CYP11B1 and subsequent 
enhanced production of cortisol was induced by the proinflammatory cytokine IL-1β and 
depressed by insulin-like growth factor 1 (IGF-1) [19]. In the same study elevation of cortisol 
synthesis was observed approximately 48 hours after acute injury and maintained the 
proper wound healing.  
In conclusion, the skin possesses an autonomous HPA axis, regulating the normal integrity 
and growth, and is able to respond to stress factors. At the same time the GC-synthesizing 
machinery of the skin can be stimulated by inflammatory mediators in order to provide an 
adequate local self-limitation of immune responses. 
3.3. Central nervous system 
The term neurosteroids was defined after the discovery that various steroid metabolites can 
be detected in the brain of simultaneously adrenalectomized and gonadectomized rats [30]. 
Among the locally synthesized and active steroids are pregnenolone and pregnenolone 
sulphate, progesterone, allopregnanolone, dehydroepiandrosterone and 
dehydroepiandrosterone sulphate. These steroids can exert their effects in neurogenesis, 
development, myelinization, memory, reactions to stress through engaging nuclear 
receptors and modulating transcription, as well as affecting neurotransmission by 
modifying the activity of gamma-aminobutiric acid (GABAA), N-methyl-D-aspartic acid 
(NMDA), and sigma receptors (for review [31, 32, 68]). Low levels of transcripts for 
CYP11A1, CYP11B1 and the other enzymes of corticosterone synthesis were detected in 
normal rat brain, in cerebral cortex and cerebellum [33], and 11β-hydroxylase protein 
expression was later demonstrated in the Purkinje cells and other cells of the hippocampus 
[35]. In vitro conversion of precursors into corticosterone has also been demonstrated in rat 
fetal hippocampal neurons [34]. The extremely low levels of CYP21 transcripts and enzyme 
(deoxycorticosterone synthetase, P450C21) detected [36] gave raise to many doubts whether 
complete GC synthesis can be sustained in the brain. Nevertheless, the activity of brain 
tissue to convert progesterone to 11-deoxycorticosterone (resp. 17α-OH-progesterone to 11-
deoxycortisol) pointed out that steroid metabolism in the brain exists. Recently, the 
expression of isoforms of CYP2D4 and CYP2D6 in rat and human brains, respectively, as 
well as demonstration of their 21-hydroxylation activity confirmed the capacity of rodent 
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and human brain to produce GC locally [37, 69], though suggesting a slightly different 
enzymatic pathway compared to that of the adrenals. Nonetheless, CRF and ACTH, likely 
released by the hypothalamus, resp. pituitary gland, seem to regulate GC synthesis in the 
brain in a similar manner as in the adrenals. Interestingly, adrenalectomy even increases the 
expression of CYP11B1 in the rat brain [70]. 
Peripheral reactivation of 11-dehydrocorticosterone to corticosterone, resp. cortisone to 
cortisol via 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) activity contributes 
considerably not only to the local concentrations and effects of GC, but also to the plasma 
level of GC, as shown by an almost 30% increase in corticosterone levels in the portal vein 
compared to the incoming arterial circulation [38, 39, 71]. In the brain 11β-HSD1 expression 
was found in various areas. Local levels of corticosterone in the cerebral cortex, 
hippocampus, hypothalamus and pituitary gland modulate the activity of the HPA axis. 
This effect is particularly apparent in 11β-HSD1 knockout mice. The lack of 11β-HSD1 
activity in the brain of these mice leads to considerably reduced local levels of 
corticosterone. Hence, the HPA axis is hyperactivated and higher amounts of ACTH are 
produced, which in turn causes adrenal hypertrophy. Normal or even elevated systemic 
GC fail to transmit proper feedback responses to the hypothalamus [40-42]. Other curious 
effects of the local levels of GC attributed to the activity of 11β-HSD1 in the hippocampus 
are cognitive disorders during aging. Experiments in 11β-HSD1-deficient mice showed 
that these animals are protected from the decline of the learning abilities [43, 72]. 11β-
HSD1 is expressed in the human prefrontal cortex, cerebellum and hippocampus, and its 
expression, as well as local GC levels, has also been correlated to the cognitive decline in 
elderly patients [44, 45], [42]. Furthermore, some clinical studies showed an improvement 
in verbal fluency and memory in patients treated with the specific 11β-HSD1 inhibitor 
carbenoxolone [44].  
3.4. Cardiovascular system 
The impact of mineralocorticoids and glucocorticoids on the heart and blood vessels is well 
known and described. Yet, the capacity of these structures to sustain their own supplies is 
not understood in detail. Data obtained mainly in rats indicate that vascular tissue expresses 
steroidogenic factors, such as StAR, CYP11A1, CYP11B1 and CYP11B2 [20, 21, 73]. Ex vivo 
cultured rat blood vessels were able to produce corticosterone and aldosterone [23, 73]. 
Expression of various steroidogenic enzymes has been shown also in the human heart and 
blood vessels [26, 27]. However, CYP11B1 and CYP11B2 expression was only demonstrated 
in patients with myocardial infarction and heart failure [28], but barely under steady state 
conditions or in cultured endothelial cells [29], suggesting that local GC synthesis may be 
triggered during pathological conditions. Presence of CYP11B2 (aldosterone synthetase) and 
the fact that steroidogenesis in the cardiovascular system is triggered by the angiotensin 
signaling system [24] points out that local steroidogensis in the vascular systems is 
connected to the renin-angiotensin-aldosterone regulatory mechanisms [25]. Local 
reactivation of 11-dehydrocorticosterone was also observed in the smooth muscle cells in 
arteries, where it may contribute to vascular contractility and remodeling [74], [75]. Despite 
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a clear demonstration of steroidogenesis in the vasculature detailed studies on the anti-
inflammatory role of local GC synthesis in blood vessels are still missing. 
In addition to the different tissues described above local GC synthesis was also reported in the 
placenta [76], the ovaries [77], the testis [78], the uterus [79], and the mammary gland [80].  
4. GC synthesis in mucosal tissues 
Mucosal surfaces in the gastrointestinal, respiratory and urinal tract represent important 
contact zones between the body and the outside world. They exert important functions in 
the exchange of nutrients, gases and other substances between the organism and the 
surrounding world. They comprise an enormous interactive surface and are thereby also 
constantly exposed to various antigens and microorganisms. Though, most of them are 
harmless, and thus the body has developed mechanisms to tolerate these harmless antigens. 
Yet, dangerous infections of the lung and the intestine occur, in which case the local defense 
machinery must be engaged to protect the host from invasion. The barrier between inside 
and outside is primarily formed of a simple one-layered epithelium with the respective 
specialized functions. Beneath the epithelial layer in the lamina propria of the intestine or in 
the interstitium of the lung resides a large number of immune cells. Clearly the huge 
mucosal surface must be protected from invading pathogens, and thus these epithelial 
tissues are home of the largest immune system in our body. Inappropriate activation of 
these local immune cells by environmental antigens, though, can result in uncontrolled 
inflammation and associated tissue destruction. Several lines of evidence discussed in detail 
below indicate that locally produced GC significantly contribute to the regulation of local 
immune responses and the maintenance of immune homeostasis in these epithelial tissues. 
4.1. GC synthesis in the intestinal epithelium 
In the intestinal mucosa two super-systems collide. The intestinal lumen hosts ten times 
more bacteria than cells in our body are found. At the same time, the intestinal epithelium 
and lamina propria are also home of the largest number of B and T cells, and are also 
densely populated by macrophages and dendritic cells. Accidental and uncontrolled 
activation of these cells and/or other infiltrating immune cells by harmless commensal 
bacteria or food antigens is the underlying cause of a variety of inflammatory disorders, 
such as inflammatory bowel disease and food allergies [81] 
There is accumulating evidence that local production of immunoregulatory GC significantly 
contributes to the control of intestinal immune homeostasis and prevents a clash between 
immune cells and commensal bacteria. The notion that the intestinal mucosa could be a 
steroidogenic organ has been already suggested some time ago, when it was found that 
genetic deletion of the nuclear receptor SF-1 (steroidogenic factor-1, NR5a1), largely 
responsible for the transcriptional control of the adrenal development and GC synthesis, could 
not abrogate intestinal CYP11A1 expression in the mouse embryonic gut [82]. At the same 
time remaining GC levels were observed in the circulation of prenatal mice, indicating that an 
extra-adrenal source of GC synthesis must exist [83]. Our own research started to explicitly 
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investigate the possibility that the intestinal mucosa is an important source of 
immunoregulatory GC some ten years ago. Investigating the function of so-called intraepithelial 
lymphocytes, T cells that reside within the intestinal epithelial layer, it was found that these cells 
rapidly died upon isolation and ex vivo culture, but could be partially rescued when the GR 
was blocked by the receptor antagonist RU-486 [84]. This observation suggested that these 
intestinal T cells were constantly exposed to GC, and that removal of survival signals, e.g. by 
detachment from the epithelial layer, would promote GR-dependent apoptosis. 
Subsequent studies revealed that the intestinal mucosa is home of a complex steroidogenic 
system, likely adapted to cope with the specialized environment of the gut. Many of the 
steroidogenic enzymes required for the synthesis of corticosterone from cholesterol or the 
reactivation of corticosterone from dehydrocorticosterone are constitutively expressed in the 
intestinal epithelium, whereas other enzymes become strongly induced upon 
immunological stress [46, 52, 53]. The ability of the intestinal tissue to synthesize 
corticosterone in mice [46] and humans [55] indicates that the intestinal mucosa expresses 
the complete and functional enzymatic machinery. This steroidogenic capacity is further 
confirmed by the use of metyrapone, a potent 11β-hydroxylase inhibitor with some 
inhibitory effects also on P450scc and 11β-HSD1, which efficiently blocks ex vivo GC 
synthesis in intestinal organ cultures [46, 55], confirming that GC measured were produced 
locally in the tissue. 
While in most experiments and ex vivo organ cultures basal GC levels are detected, a 
significant induction is usually observed, when mice are stressed by immune cell-activating 
agents. Administration of T cell-activating anti-CD3ε antibody, macrophage-activating 
lipopolysaccharides, or TNFα, infection of mice with viruses or chemically induced 
intestinal inflammation promotes the expression of certain steroidogenic enzymes, e.g. 
CYP11A1 and CYP11B1, and strongly stimulates the synthesis of intestinal GC. In some of 
these in vivo experiments a role of intestinal GC synthesis in the control of intestinal 
immune cells could also be confirmed. Most pronounced are the effects reported on viral 
infection and experimental colitis. Infection of mice with the lymphocytic choriomeningitis 
virus (LCMV) leads to a rapid expansion of the virus, which infects various target organs, 
including the intestine [46, 85, 86]. The virus promotes a massive expansion of virus-specific 
cytotoxic T cells, which in turn control the viral expansion by killing virus-infected cells. 
Employing this experimental system it has been shown that intestinal T cells from mice with 
deregulated intestinal GC synthesis (using the pharmacological inhibitor of GC synthesis 
metyrapone) became more profoundly activated by the virus, and expressed activation 
markers and inflammatory cytokines at much higher levels [46]. Similarly, in experimental 
models of colitis defective intestinal GC synthesis resulted in a more rapid and more 
pronounced induction of intestinal inflammation, as monitored by immune cell infiltration, 
epithelial layer damage, weight loss, etc. [49, 53].  
4.2. Regulation of intestinal GC synthesis 
The regulation of adrenal GC synthesis has been well documented over many decades of 
research (reviewed in [87]). The connection between physical, emotional and immunological 
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stress, and the activation of the HPA axis has been well established. Similarly, the role of the 
hormone ACTH in stimulating adrenal GC synthesis, and the nuclear receptor SF-1 in the 
transcriptional control of adrenal steroidogenesis is widely accepted [88]. In agreement with 
this critical role of SF-1 in the induction of steroidogenic enzymes in the adrenal glands is 
the observation that mice deficient for SF-1 have no detectable corticosterone in the serum. 
In fact, SF-1-deficient mice even lack adrenal glands, as SF-1 is also required for the 
embryonic development of the adrenal glands. As discussed above, mice lacking SF-1 
expression still express the steroidogenic enzyme gene CYP11A1 in the primitive gut of 
embryonic mice, supporting the notion that in the intestine steroidogensis is differentially 
controlled. Along these lines, it was found that SF-1 expression is basically absent in the 
intestine, but functionally replaced by its close homolog LRH-1 (liver receptor homolog-1, 
NR5a2). LRH-1 has strong sequence homology with SF-1, and regulates gene expression by 
binding to identical transcription factor response elements in the promoter of their target 
genes [47]. In general, SF-1 and LRH-1 have a mutually exclusive expression pattern, with 
very low LRH-1 expression in the adrenals, but very high expression in epithelial cells from 
the liver, pancreas, intestine and ovaries [89]. 
The role of LRH-1 in the regulation of extra-adrenal GC synthesis in the intestine has been 
investigated in intestinal epithelial cell lines in vitro as well as in vivo models [47, 49]. 
Overexpression of LRH-1 in intestinal epithelial cells induces the expression of the 
steroidogenic enzymes CYP11A1 and CYP11B1, and mutation of corresponding response 
elements in their promoter abrogates their LRH-1- and SF-1-induced activation [47]. 
Similarly, inhibition of LRH-1 expression or function leads to reduced expression of these 
steroidogenic enzymes in intestinal epithelial cells. Overexpression of LRH-1 in turn directly 
promotes detectable levels of corticosterone in the supernatant of intestinal epithelial cell 
cultures. In vivo the role of LRH-1 has been investigated by the use of LRH-1 haplodeficient 
as well as conditional LRH-1 knockout mice [48, 49]. LRH-1 haplodeficient mice showed a 
largely reduced induction of steroidogenic enzymes after anti-CD3ε injection and a complete 
block in intestinal GC synthesis induction, confirming an important role of LRH-1 in the 
regulation of intestinal GC synthesis. While induction of DSS (dextran sodium sulfate)- or 
TNBS (trinitrobenzen sulfonic acid)-mediated colitis stimulates the expression of steroidogenic 
enzmymes and a transient intestinal GC synthesis [51], deletion of LRH-1 in intestinal 
epithelial cells largely abrogates intestinal steroidogenesis [49]. More importantly, absence of 
LRH-1 and associated intestinal GC synthesis also leads to a more pronounced and accelerated 
colitis, confirming an important role of LRH-1 and intestinal GC synthesis in the regulation of 
local immune responses. LRH-1 likely regulates intestinal GC synthesis not only via the 
induction of certain steroidogenic enzymes. Steroid acute regulator (StAR) has an important 
role in transporting cholesterol within the cell, and thus supplying the steroid synthesizing 
machinery with the substrate for GC synthesis. As LRH-1 also transcriptionally regulates StAR 
expression [90], LRH-1 seems to control intestinal GC synthesis at many levels. 
Interestingly, LRH-1 appears to have various modes of activation. Though initially 
defined as orphan nuclear receptor due the lack of known ligands, the crystallization of 
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LRH-1 and subsequent structural analysis revealed a ligand binding to the ligand-binding 
domain of LRH-1. This ligand was identified as phosphatidylinositol, however, it is very 
likely that a larger variety of natural and synthetic ligands may bind to this ligand-
binding domain and transactivate LRH-1. Of interest are recent reports demonstrating 
LRH-1 activation by testosterone [91], the herbizide atrazin [92] as well as several 
synthetic ligands with selective activities for LRH-1 over SF-1 [93]. However, ligand 
binding may not be an absolute requirement for LRH-1 activation. In particular, mouse 
LRH-1 can be activated in a ligand-independent manner, as mutation of the ligand-
binding domain does not affect its activity [94]. 
In marked contrast, phosphorylation by upstream kinases may selectively activate both, 
human and mouse LRH-1. Two serine residues in the hinge region of LRH-1 have been 
identified as phosphorylation targets of the MAP kinase ERK1/2, and mutation of these two 
serine residues strongly affects LRH-1 activity [95]. In line with this idea of LRH-1 activation 
via the MAP kinase pathway is the observation that the MEK1 inhibitor U0126 also blocks 
LRH-1 activity ([95]; Bianchi, Brunner, unpublished). Next to ERK1/2 also other yet to be 
identified kinases may be involved in LRH-1 phosphorylation and activation. 
As many other nuclear receptors LRH-1 is also efficiently regulated by cofactors and 
repressors. For example, SRC-1 (steroid receptor coactivator-1) binds to LRH-1 and 
enhances its transcriptional activity. On the other hand, various inhibitors of LRH-1, such as 
DAX-1 (dosage-sensitive sex reversal, adrenal hypoplasia critical region, on chromosome X, 
gene 1), SHP (small heterodimer partner) and Prox-1 (Prospero homeobox protein 1) have 
been shown to interact with LRH-1 and inhibit its activity [89, 96, 97]. Of interest is the fact 
that SHP is a major transcriptional target of LRH-1, and SHP induction likely represents a 
negative feedback loop terminating the transcriptional activity of LRH-1. 
Thus far intestinal GC synthesis has been always described in the context of immunological 
stress and inflammation. Clearly, factors released by activated immune cells must be able to 
trigger steroidogenesis in intestinal epithelial cells, likely via the activation of LRH-1. Of 
major interest in this regard are factors that also promote adrenal GC synthesis. 
Surprisingly, ACTH or ACTH receptor signaling pathways, such as an increase in cellular 
cyclic AMP, fail to promote intestinal GC synthesis and rather inhibit it [47] indicating that 
next to the preferential use of SF-1 and LRH-1 there are other elements in the regulation of 
adrenal versus intestinal GC synthesis that are different. The pro-inflammatory cytokines 
IL-6 and TNFα are known as potent triggers of adrenal GC synthesis. While no evidence 
could be found for a role of IL-6 in the immune cell-mediated induction of intestinal steroid 
synthesis, TNFα appears to represent a critical mediator of intestinal GC synthesis. TNFα 
alone promotes the expression of steroidogenic enzymes in intestinal epithelial cells in vitro 
and in vivo, and stimulates the synthesis of corticosterone. More importantly, induction of 
intestinal GC synthesis by injection of anti-CD3ε, LPS as well as experimental colitis largely 
depends on the signaling via TNF receptors [53]. Surprisingly, deletion of either one of the 
two TNF receptors abrogates immune cell-induced intestinal GC synthesis [52], indicating 
that simultaneous signaling via both receptors is required.  
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The important role of TNFα in the induction of intestinal GC synthesis is particularly 
evident when analyzing different models of experimentally induced colitis. While DSS and 
the hapten TNBS promote intestinal steroidogenesis, the hapten oxazolone fails to do so, 
despite very comparable induction of inflammation [53]. Clearly, inflammation alone is 
insufficient to initiate intestinal steroidogensis, but the type of inflammation may be critical. 
DSS and TNBS stimulate an immune response with Th1 cytokine predominance, abundant 
TNFα and IFNγ, whereas oxazolone promotes a Th2 type cytokine response with no TNFα, 
but IL-4 and IL-5. Supporting the important role of TNFα in these processes, it was found 
that oxazolone does not trigger intestinal GC synthesis, however injection of recombinant 
TNFα can restore the expression of steroidogenic enzymes and GC synthesis, and thereby 
ameliorate intestinal inflammation induced by oxazolone. Thus, TNFα seems to be an 
important sensor of immunological stress in the intestine and responsible for initiating 
negative feedback mechanisms via the induction of intestinal GC synthesis. This is 
inasmuch surprising as TNFα is an important therapeutic target in the pathogenesis of 
inflammatory bowel disease (IBD), such as Crohn’s disease and ulcerative colitis [98-100]. 
TNFα is an important disease promoting and initiating factor during IBD, and its 
neutralization inhibits inflammatory processes right from the start. Its role in the regulation 
of intestinal GC synthesis, however, point also out a thus far unrecognized anti-
inflammatory role of TNFα (reviewed in [51]).  
4.3. GC synthesis in the lung  
The intestinal and the lung epithelium have much in common. Their main function is the 
absorption of nutrients and gases, respectively, and due to their enormous surface to cope 
with this task they are also constantly exposed to a plethora of antigens, microbes and 
potential pathogens. Thus, much alike the intestinal mucosa the lung harbors a large 
number of resident immune cells, mostly macrophages and dendritic cells, and is rapidly 
populated by infiltrating immune cells upon infection or stimulation with antigens. 
Similarly, uncontrolled immune responses in the lung may lead to chronic disorders, such 
as allergen-induced asthma and chronic obstructive pulmonary disorder (COPD). This 
illustrates on one hand the need for an efficient immune response in the lung in order to 
defend this vast epithelial surface from infection and invasion by pathogens, but also points 
out that local immune responses must be tightly regulated to avoid chronic inflammation, 
tissue damage and resulting loss of function of the absorptive epithelium. 
All these thoughts suggest that similar regulatory mechanisms exist in the lung as in the 
intestinal mucosa, and local GC synthesis may represent such a homeostatic control 
mechanism. Indeed, it has been described that genes involved in the GC synthesis pathway 
are transiently expressed in the developing mouse lung [101]. More recently, our own 
research has investigated the capacity of the adult lung to express steroidogenic enzymes 
and to synthesize GC in response to immunological stress [54]. Unlike the intestinal 
epithelium, the entire enzymatic machinery appears to be constitutively expressed in the 
adult lung tissue, and only CYP11A1, encoding P450scc, is induced upon immunological 
stress initiated by injection of T cell-activating anti-CD3ε antibody or macrophage-activating 
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LPS. Furthermore, particularly CYP11B1, although detectable by quantitative PCR, seems to 
be expressed at very low levels and not to be induced as in the intestine. When analyzing 
corticosterone synthesis in ex vivo lung cultures two observations are compelling. The lung 
tissue constitutively synthesizes considerable amounts of corticosterone in unchallenged 
mice, and the induced GC levels upon immunological stress are much higher when 
compared to equal amounts of tissue in the intestine [54]. Importantly, also in the lung ex 
vivo GC synthesis is efficiently blocked by the pharmacological inhibitor metyrapone, 
supporting the idea that GC measured are de novo synthesized in the lung tissue, though 
here its effect may not be via the inhibition of 11β-hydroxylase. This indicates that the lung 
tissue may be an even more potent extra-adrenal source of immunoregulatory GC than the 
intestinal epithelium.  
Thus far, the cellular source of lung GC synthesis has not been identified yet. Very likely, 
though, lung epithelial cells, either type I or type II epithelial cells, may be the relevant 
source of lung GC. In support of this hypothesis is the observation that lung epithelial cell 
lines express steroidogenic enzymes and are capable of metabolizing steroid precursors to 
corticosterone (Hostettler, Brunner, unpublished observations). Despite the many 
similarities between the intestinal and the lung epithelium in terms of response to 
inflammatory triggers and the synthesis of GC, there are also many differences in the 
induction of intestinal versus lung GC synthesis. While systemic activation of immune cells 
by anti-CD3 or LPS injection triggers both, intestinal and lung GC synthesis [52, 54], the 
response to local inflammation seems to be regulated somewhat differently. A typical model 
of allergic airway inflammation is the sensitization of mice with the model antigen 
ovalbumin in the context of alum as adjuvant, and the challenge with the antigen via 
aerosol. This leads to a T helper 2 type inflammatory response with a major eosinophilic and 
neutrophilic granulocyte infiltration of the lung tissue and lung lumen within 24 hours. 
Despite the massive inflammation and infiltration with immune cells only a minimal and 
not significant transient increase in local GC synthesis is observed, not comparable to the 
high concentrations measured after stimulation with anti-CD3 or LPS [54]. Given the fact 
that ovalbumin airway hypersensitivity and oxazolone-induced colitis are both T helper 2-
driven immune responses, the idea that lack of TNFα secretion could be the missing 
stimulator of lung GC synthesis appears very attractive. Indeed, only minimal TNFα levels 
are measured in the serum and the bronchoalveolar lavage (BAL) after ovalbumin challenge 
[54]. Similarly, when TNFα is injected into mice local GC synthesis in the lung can be 
efficiently induced. However, experiments in TNF receptor-deficient mice using anti-CD3 as 
a trigger clearly showed that TNFα signaling is not required for immune cell-stimulated 
local GC synthesis in the lung tissue. Thus, very likely other cytokines and/or factors, yet to 
be identified, may be substituting TNFα as a sensor of immune cell activation and trigger of 
local GC synthesis. It is feasible to believe that such a sensor of immunological stress is not 
induced during allergic inflammation of the lung, e.g. asthma, but present during contact 
with pathogens, such as influenza infection, thereby helping to reestablish local immune 
homeostasis via the secretion of GC. The identification of this or these critical inducers of 
local GC synthesis may lead to interesting targets for therapeutic intervention of chronic 
inflammation of the lung via the induction of local GC synthesis.  
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4.4. Regulation of lung GC synthesis 
Presently, not much is know regarding the molecular mechanisms of lung GC synthesis, and 
more detailed analysis of the regulatory pathways leading to the induction and activation of 
steroidogenic enzymes in the lung tissue will be needed. While the presence of all 
steroidogenic enzymes required for the synthesis of corticosterone from cholesterol suggests 
identical synthesis pathways in the lung, adrenals and intestine, metabolic assays indicate 
major differences between the tissues. Interestingly, ex vivo cultured lung tissue failed to 
convert radioactively labeled deoxycorticosterone into corticosterone, suggesting that the 
expression levels of CYP11B1/11β-hydroxylase are insufficient to promote this pathway of 
GC synthesis. In contrast, dehydrocorticosterone is efficiently metabolized by the lung tissue 
into corticosterone, supporting the idea that reactivation of inactive serum 
dehydrocorticosterone via an 11β-HDS1-dependent pathway is the primary corticosterone 
synthesis pathway in the lung. Along these lines is the observation that the lung expresses 
very low levels of CYP11B1 but very high levels of HSD11B1, and that adrenalectomy 
completely abolishes lung GC synthesis [54]. Though metyrapone has been reported to be 
selective for 11β-hydroxylase, inhibition of 11β-HSD1 has also been noted [102], explaining 
why ex vivo GC synthesis in lung tissue is efficiently blocked by metyrapone. A dominant 
role for an 11β-HSD1-dependent corticosterone synthesis pathway is also supported by the 
lack of evidence for a role of LRH-1 in the regulation of lung GC synthesis. While anti-CD3-
induced intestinal GC synthesis was significantly reduced in LRH-1 haplodeficient mice 
[48], lung GC synthesis was found to be normal [54], indicating that other nuclear receptors 
or transcription factors are involved in the regulation of steroidogenesis in the lung tissue. 
5. GC synthesis in colorectal tumors 
The role of tumor immunology in the surveillance of transformed cells and the control of 
tumor development is a highly controversial issue. While tumor-specific immune responses 
and even tumor-specific T cells can be demonstrated in certain types of tumors, stimulation 
of tumor-specific T cells by immunization has thus far not been too successful in the 
prevention or treatment of tumors. A major exception is the vaccination against human 
papilloma virus, which strongly reduces the incidence of cervical cancer [103, 104]. Despite 
relatively disappointing results of such immunization protocols, clinical and histological 
studies support the notion that tumor-infiltrating leukocytes (TIL) are indeed capable of 
limiting the growth and development of certain types of cancer. An extensive study in 
patients with colorectal cancer revealed that those patients that had a pronounced 
infiltration of the tumor with lymphocytes, and in particular with memory T cells, showed a 
significantly prolonged survival compared to patients with little or no immune cell infiltrate 
[105]. Though an indirect proof, these studies demonstrate a strong correlation between 
anti-tumor immune responses, tumor development and patient survival. These findings, 
however, also suggest that tumors capable of escaping or suppressing immune responses by 
any means may have a major advantage and kill the patient more rapidly.  
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Various immune escape mechanisms have been described in different tumors. Tumor cells 
secrete suppressive cytokines, such as TGFβ and IL-10, express pro-apoptotic ligands (Fas 
ligand and TRAIL), which kill TIL, or simply reduce their immunogenicity by 
downregulating MHC molecules and associated antigen presentation on their surface. In this 
paragraph we will also discuss the proposed role of extra-adrenal GC synthesis in colorectal 
tumors as a mechanism of immune escape. Though various types of tumors have been shown 
to be active sources of steroid hormones, most of these tumors derive from steroidogenic 
tissues, such as the adrenal glands, ovaries or testis. For example, adrenal hyperplasia and 
tumors often lead to a massive release of GC, resulting in Cushing syndrome [106]. In 
addition, small cell bronchogenic carcinoma, carcinoids of thymus, pancreas, ovary, as well as 
medullary carcinoma of thyroid gland etc. have been shown to release ACTH or in rare cases 
CRH, and thereby to stimulate indirectly the release of systemic GC from the adrenals with 
subsequent suppression of the immune system [107, 108]. Yet, thus far no direct GC synthesis 
in tumors from non-steroidogenic tissues has been described. 
As discussed in detail above, LRH-1 has a prominent role in the regulation of intestinal GC 
synthesis [48, 52]. Interestingly, however, LRH-1 has also been implicated in other aspects of 
intestinal epithelial cell biology. LRH-1 is primarily expressed in the pluripotent and 
proliferating cells of the intestinal crypts where it regulates the expression of cyclin D1. 
Furthermore, in collaboration with the Wnt signaling pathway and β-catenin it also controls 
the expression of cyclin E1 and c-Myc, and thereby the proliferation of crypt cells and the 
renewal of the intestinal epithelial layer (reviewed in [109, 110]). Not surprisingly, this 
mitogenic role of LRH-1 appears to be also involved in the development of intestinal 
tumors. Mice with a mutation in the APC gene (APCmin/+ mice) spontaneously develop 
adenomas in both small and large bowel. Interestingly tumor development is significantly 
reduced in mice with LRH-1 deficiency [111]. Thus, LRH-1 appears to be a proto-oncogene 
in the development of intestinal tumors. In line with this idea is the observation that 
different tumors derived from endoderm tissue show LRH-1 overexpression. For example, 
LRH-1 is overexpressed in colorectal [55] and in pancreatic tumors [112], where it also 
regulates cell cycle progression. 
Given the important role of LRH-1 in cell cycle regulation as well as intestinal GC synthesis 
LRH-1-mediated synthesis of immunoregulatory GC in colorectal tumors as a mechanism to 
control anti-tumor immune responses appears to be an attractive idea. Indeed, considerable 
synthesis of cortisol can be measured in colorectal cancer cell lines as well as primary 
colorectal tumors using radioimmuno assay, bioassay as well as metabolic assays [55]. In 
line with this steroidogenic potential of colorectal tumor cells is the widely distributed 
expression of LRH-1 and steroidogenic enzymes. Furthermore, overexpression of LRH-1 
further boost the expression of steroidogenic enyzmes and the synthesis of cortisol, whereas 
inhibition of LRH-1 expression downregulates these processes. Interestingly, GC synthesis 
in colorectal tumor cell lines as well as ex vivo cultured primary tumors seems to be 
constitutive, whereas in normal colonic tissue it is inducible by phorbol ester, likely via the 
ERK1/2-mediated activation of LRH-1. This suggests that in colorectal tumors LRH-1 may be 
constitutively active, and suggests that signal transduction pathways leading to tumor 
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development and proliferation also govern the activation of LRH-1 and associated GC 
synthesis. Of interest in this regard is that LRH-1 not only controls cell cycle progression, 
but that its activity is also controlled by the cell cycle [50]. Various mitogenic signals 
controlling tumor cell proliferation may therefore also promote the activation of LRH-1. In 
line with this idea is the observation that many colorectal tumors have activating mutations 
of the epidermal growth factor receptor pathway [113] and that epidermal growth factor can 
stimulate LRH-1 activation in an ERK1/2-dependent manner in Hela cells [95]. However, 
more detailed analysis of the signaling pathways leading to LRH-1 activation and GC 
synthesis in colorectal tumors will be required to confirm whether mitogenic stimuli are 
indeed important triggers of extra-adrenal GC synthesis in tumor cells. 
 
Abbreviations: B – B-Lymphocytes; DC – dendritic cells; LPS – lipopolysaccharides; Mϕ – macrophages; NK – natural 
killer cells; T – T-Lymphocytes; Tu – tumor cells. 
Figure 2. Proposed role of intestinal GC synthesis in maintaining immune homeostasis in normal gut 
mucosa and promoting immune escape in colon cancer. 
While the immunoregulatory role of GC synthesis in normal intestinal tissue is quite well 
established [46, 49, 52, 53], the evidence in colorectal tumors is yet relatively indirect. The 
supernatant of colorectal tumor cell lines and primary tumors has been found to contain a 
suppressive activity, which inhibits the activation of primary T cells, as measured by the 
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induction of activation marker CD69 [55]. Similarly, tumor-derived supernatant was able to 
promote apoptosis in GC sensitive immune cells. Importantly, these suppressive or pro-
apoptotic activities were blocked by either interfering with the GC synthesis pathway in 
tumor cells by metyrapone, or by blocking the GR in immune cells [55]. While colorectal 
tumor cells may also secrete other immunoregulatory factors, such as TGFβ, these finding 
demonstrate that GC are present in the supernatant of tumor cells and that their 
concentration is high enough to promote biological responses and immunosuppression. The 
secretion of immunoregulatory GC by colorectal tumors may thus represent a novel 
mechanism how tumor cells escape from destruction by the immune system. Similar 
mechanisms may also exist in tumors from tissues capable of secreting bioactive GC, e.g. 
lung cancer. 
6. Conclusion 
In summary, the extremely potent GC synthesizing activity of the adrenal glands has 
obscured for a long time the fact that various other extra-adrenal tissues are important 
sources of immunoregulatory GC. This chapter has highlighted in particular the role of the 
pulmonary and intestinal mucosa, and its associated tumors, as potent sources of extra-
adrenal GC synthesis. Their more recent identification has lead to new interpretations of 
how locally produced GC may be involved in the maintenance of tissue homeostasis, 
regulation of inflammatory processes and tumor development. Finally, the detailed analysis 
of the differential signal transduction pathways controlling GC synthesis in the adrenals 
versus extra-adrenal tissues may offer novel opportunities for the development of 
therapeutic interventions. 
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